FDA Investigator Malgorzata G Norton, PhD

Malgorzata G Norton, PhD has conducted inspections on 11 sites in 3 countries as of 09 Nov 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
11
Last Inspection Date:
09 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
France, United States of America, Korea (Republic of)
FDA Investigators that have inspected at least one site in common with Malgorzata G Norton, PhD:
Abby Lmozeke Baker, Ann M Stewart, Annet R Rajan, Anthony F Lorenzo, Anthony W Lee, Arie C Menachem, Binh T Nguyen, Bradley Dworak, PhD, Brooke K Higgins, Brooke K Seeman, Burnell M Henry, Carol L Rehkopf, Carole L Jones, Christian D Lynch (CDL), Cynthia Jim, CSO, David Galler Veety, Deborah M Trout, Decarlos A Gomez, Derek S Smith, PhD, Diane T Bargo, Diane T O'brien, Douglas A Campbell, Eileen A Liu, Eliezar Ramos, Emest F Bizjak, Ephrem Hunde, PhD, Gabriel M Guevarra, Gene D Arcy, Gerald B Seaborn, Jr, Gregory Price, Helen B Ricalde, Holly Brevig, Hongna Wang, Irina Gaberman, Jacqueline Mdiaz Albertini, James P Stumpff, James W Leonette, Janet A Rajan, Jennifer L Reed, Jessica Hankins, PhD, Joan A Loreng, Joan Johnson, John M Mcinnis, Jonathan W Chapman, Joseph George, Katherine E Jacobitz, Kathleen M Jordan, Kelly L Anderson, Kenneth Nieves, Kham Phommachanh, Laurel A Beer, LCDR Debra Emerson, Lewis K Antwi, Linda Thai, Lori S Lawless, Lu Deng, Marion Michaelis, Mariza M Jafary, Melissa J Garcia, Merideth K Rose, Michael C Kennedy, PhD, Michael J Vardon, Mihaly S Ligmond, Minh D Phan, Nancy T Waites, Nebil A Oumer, Nicholas A Violand, Nicole K Trudel, Nicole M Li, Nobuko H Katagiri, Obinna R Echeozo, Olga Simakova, PhD, Omotunde O Osunsanmi, Pankaj H Amin, Paula A Trost, Peng Zhou, Prabhu P Raju, Pratik S Upadhyay, DDC, Quyen T Tran, Rachel C Harrington, Randa Melhem, PhD, Raymond W Brullo, Regina Gibson Melton, Richard Heath Coats, Richard W Thornton, Robert J Martin, Robert Jennings, Roger F Zabinski, Sarah B Tanksley, Scott T Ballard, Sena G Dissmeyer, Shafiq S Ahadi, Sonya L Karsik, RAC, Steven P Donald, Susan M Jackson, Tamala P Bogan, Tamala P Magee, Tania Y Hall, Timothy M Martin, Toyin B Oladimeji, Travis S Bradley, Unnee Ranjan, Vijaya L Simhadri, Vioela J Caze, Walter L Fava, William A Warnick, William H Linkroum, Xiaokuang Lai, PhD, Xiuju Lu, Yasamin Ameri, Yonggang Wang, PhD, Zuben E Sauna, PhD

Malgorzata G Norton, PhD's Documents

Publish Date Document Type Title
August, 2018 FDA 483 Kedrion Biopharma Inc. - Form 483, 2018-08-29
September, 2019 FDA 483 Grifols Biologicals LLC - Form 483, 2019-09-12
January, 2013 FDA 483 SANOFI WINTHROP INDUSTRIE - Form 483, 2013-01-23
June, 2018 EIR Cangene BioPharma, LLC - EIR, 2018-06-13
September, 2019 FDA 483 Grifols Biologicals LLC - Form 483, 2019-09-12
September, 2012 FDA 483 BAXALTA US INC. - Form 483, 2012-09-20
June, 2018 FDA 483 Cangene BioPharma, LLC - Form 483, 2018-06-13
June, 2018 FDA 483 Response Cangene BioPharma, LLC - Form 483R, 2018-07-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more